Case/Histology | Antigens (% of positive tumour cells/staining intensity) | |||||||
---|---|---|---|---|---|---|---|---|
EGFR | Her-2 | Her-3 | Her-4 | AR | ER | PR | ||
apo, apocrine features; AR, androgen receptor; casa, carcinosarcoma—epithelial staining; casa, carcinosarcoma—stromal staining; EGFR, epithelial growth factor receptor; ep, epithelioid; ER, oestrogen receptor; fasc, fascicular; GC, giant cells; het, heterologous elements; IDC, invasive ductal carcinoma; mat, matrix producing; PR, progesterone receptor. | ||||||||
1 Spindle/het | 20 | 2+ | 50/1+ | – | – | – | – | – |
2 Spindle/ep/het | 70 | 3+ | – | – | – | – | – | – |
3 Spindle/ep/het/GC | 40 | 2+ | – | – | – | – | – | – |
4 Spindle/het/GC | – | – | – | – | – | 90/2+ | – | – |
5 Spindle/het/GC | 20 | 1+ | – | – | – | – | – | – |
6 Spindle/het/GC | 30 | 2+ | – | – | – | – | – | – |
7 Spindle/mat | 10 | 2+ | – | – | – | – | – | – |
8 Spindle/het/GC | – | – | – | 40/1+ | 40/2+ | – | – | – |
9 Spindle/het/apo | 70 | 3+ | – | – | – | – | – | – |
10 Spindle/fasc | – | – | – | – | – | – | – | – |
11 Spindle/ep/GC | – | – | – | – | – | – | – | – |
12 Spindle/fasc | 90 | 3+ | – | – | – | – | – | – |
13 Spindle/fasc | 90 | 3+ | – | – | – | – | – | – |
14 Spindle/fasc | 100 | 3+ | – | – | – | – | – | – |
15 Spindle/fasc | 80 | 3+ | – | – | – | – | – | – |
16 Spindle/fasc | 20 | 1+ | – | – | – | – | – | – |
17 Casa/IDC | – | – | 30/2+ | – | – | 70/2+ | 70/3+ | 70/3+ |
17 Casa/spindle/GC | – | – | – | – | – | – | – | – |
18 Casa/IDC | 20 | 2+ | – | – | – | – | – | – |
18 Casa/spindle | 50 | 3+ | – | – | – | – | – | – |
19 Casa/IDC | – | – | – | – | – | – | – | – |
19 Casa/spindle/fasc | – | – | – | – | – | – | – | – |
20 Casa/IDC | – | – | 20/1+ | 20/1+ | 20/1+ | – | 30/3+ | 30/3+ |
20 Casa/spindle/fasc | 60 | 3+ | – | – | – | – | – | – |